Aphria Inc. (T:APHA*CA)

Business Focus: Alternative Medicine

Aug 23, 2019 02:15 pm ET
Aphria Inc. Files Preliminary Base Shelf Prospectus
Meets Contractual Obligations to the Convertible Debenture Syndicate Proforma cash at May 31, 2019 was over $600 million1
Aug 23, 2019 02:15 pm ET
Aphria Inc. Files Preliminary Base Shelf Prospectus
Meets Contractual Obligations to the Convertible Debenture Syndicate Proforma cash at May 31, 2019 was over $600 million1...
Aug 02, 2019 08:05 am ET
IIROC Trade Resumption - APHA
TORONTO, Aug. 2, 2019 /CNW/ - Trading resumes in:
Aug 01, 2019 04:15 pm ET
Aphria Inc. Announces 158% Increase in Adult-Use Sales and Profitable Fourth Quarter
Reports Profitable Fourth QuarterRecord Net Revenue of $128.6 Million, Up 75% from Prior Quarter Revenue for Adult-use Cannabis of $18.5 Million, Up 158% from Prior QuarterProvides Fiscal Year 2020 Outlook
Aug 01, 2019 04:15 pm ET
Aphria Inc. Announces 158% Increase in Adult-Use Sales and Profitable Fourth Quarter
Reports Profitable Fourth QuarterRecord Net Revenue of $128.6 Million, Up 75% from Prior Quarter Revenue for Adult-use Cannabis of $18.5 Million, Up 158% from Prior QuarterProvides Fiscal Year 2020 Outlook...
Aug 01, 2019 04:12 pm ET
IIROC Trading Halt - APHA
TORONTO, Aug 1, 2019 /CNW/ - The following issues have been halted by IIROC:
Jul 29, 2019 06:00 am ET
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Sensi Medical Cannabis House to open in Kingston, JamaicaInventory at Opening to Exceed 2,700 kgs
Jul 29, 2019 06:00 am ET
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Sensi Medical Cannabis House to open in Kingston, JamaicaInventory at Opening to Exceed 2,700 kgs...
Jul 18, 2019 06:00 am ET
Aphria Inc. to announce fourth quarter and fiscal 2019 financial results on August 1, 2019
LEAMINGTON, ON, July 18, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) will release results for the fourth quarter and twelve months ended May 31, 2019 on August 1, 2019 after market close.  
Jul 18, 2019 06:00 am ET
Aphria Inc. to announce fourth quarter and fiscal 2019 financial results on August 1, 2019
LEAMINGTON, ON, July 18, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) will release results for the fourth quarter and twelve months ended May 31, 2019 on August 1, 2019 after market close.  ...
Jul 08, 2019 05:00 am ET
Aphria Inc. launches Plant Positivity social impact platform
Announces partnership with the national not-for-profit Evergreen which will create six new garden spaces at Evergreen Brick Works
Jul 08, 2019 05:00 am ET
Aphria Inc. launches Plant Positivity social impact platform
Announces partnership with the national not-for-profit Evergreen which will create six new garden spaces at Evergreen Brick Works...
Jun 07, 2019 09:20 am ET
Aphria adds to planned portfolio of vapes & concentrates with PAX Labs agreement
Solei, RIFF and Aphria medical cannabis to be available for the PAX Era device and platform
May 21, 2019 06:30 am ET
Aphria Completes German Tender Process and Receives Fifth Culitvation License in Germany
Aphria Germany Represents the Only Licensed Producer Permitted to Cultivate All Three Approved Strains of Medical Cannabis in Germany
May 21, 2019 06:30 am ET
Aphria Completes German Tender Process and Receives Fifth Culitvation License in Germany
Aphria Germany Represents the Only Licensed Producer Permitted to Cultivate All Three Approved Strains of Medical Cannabis in Germany...
May 14, 2019 06:30 am ET
Aphria Inc. announces executive appointments and transition
LEADING CONSUMER PACKAGED GOODS EXECUTIVE TO LEAD APHRIA AS CHIEF OPERATING OFFICER
May 14, 2019 06:30 am ET
Aphria Inc. announces executive appointments and transition
LEADING CONSUMER PACKAGED GOODS EXECUTIVE TO LEAD APHRIA AS CHIEF OPERATING OFFICER...
May 01, 2019 04:05 pm ET
Aphria Inc. to Present at the Canaccord Genuity Cannabis Conference
LEAMINGTON, ON, May 1, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced management will present at the Canaccord Genuity Cannabis Conference on Tuesday, May 14, 2019 at 11:00 a.m. ET in New York, NY.
May 01, 2019 04:05 pm ET
Aphria Inc. to Present at the Canaccord Genuity Cannabis Conference
LEAMINGTON, ON, May 1, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced management will present at the Canaccord Genuity Cannabis Conference on Tuesday, May 14, 2019 at 11:00 a.m. ET in New York, NY....
Apr 25, 2019 06:31 pm ET
Aphria Announces Expiry and Termination of Green Growth Brands Take-Over Bid
LEAMINGTON, ON, April 25, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that the previously announced take-over bid (the "Offer") by Green Growth Brands Inc. ("GGB") has failed to meet the statutory minimum tender condition and has now expired and is terminated. As previously announced on April 15, 2019, the Company entered into a definitive agreement with GGB to accelerate the expiry date of the Offer to April 25, 2019, as well as to terminate certain arrangements with GA Opportunities Corp. ("GAOC") for consideration of $89.0 million payabl
Apr 25, 2019 06:31 pm ET
Aphria Announces Expiry and Termination of Green Growth Brands Take-Over Bid
LEAMINGTON, ON, April 25, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that the previously announced take-over bid (the "Offer") by Green Growth Brands Inc. ("GGB") has failed to meet the statutory minimum tender condition and has now expired and is terminated. As previously announced on April 15, 2019, the Company entered into a definitive agreement with GGB to accelerate the expiry date of the Offer to April 25, 2019, as well as to terminate certain arrangements with GA Opportunities Corp. ("GAOC") for consideration of $89.0 million...
Apr 23, 2019 08:39 pm ET
Aphria Announces Closing of US$300 Million 5.25% Convertible Senior Notes Offering and Exercise of US $50 Million Initial Purchasers Option in Full
LEAMINGTON, ON, April 23, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced it has closed its offering of 5.25% convertible senior notes due 2024 (the "notes") for gross proceeds of US$300 million in a private placement to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Act"), and outside the United States to non-U.S. persons in compliance with Regulation S under the Act.
Apr 23, 2019 08:39 pm ET
Aphria Announces Closing of US$300 Million 5.25% Convertible Senior Notes Offering and Exercise of US $50 Million Initial Purchasers Option in Full
LEAMINGTON, ON, April 23, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced it has closed its offering of 5.25% convertible senior notes due 2024 (the "notes") for gross proceeds of US$300 million in a private placement to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Act"), and outside the United States to non-U.S. persons in compliance with Regulation S under the Act. ...
Apr 18, 2019 04:31 pm ET
Aphria Secures Cannabis Cultivation License in Germany
LEAMINGTON, ON, April 18, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") has secured the previously announced license for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices ("BfArM"), following the conclusion of a mandatory 10-day standstill period for public contracts. Aphria was granted a cultivation license for four of the nine total lots awarded by BfArM and is awaiting the completion of the tender process for the
Apr 18, 2019 04:31 pm ET
Aphria Secures Cannabis Cultivation License in Germany
LEAMINGTON, ON, April 18, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") has secured the previously announced license for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices ("BfArM"), following the conclusion of a mandatory 10-day standstill period for public contracts. Aphria was granted a cultivation license for four of the nine total lots awarded by BfArM and is awaiting the completion of the tender process ...
Apr 17, 2019 09:46 pm ET
Aphria Announces Pricing of US$300 Million of Convertible Senior Notes
LEAMINGTON, ON, April 17, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the pricing of US$300 million aggregate principal amount of 5.25% convertible senior notes due 2024 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Act"), and outside the United States to non-U.S. persons in compliance with Regulation S under the Act. Aphria also granted the initial purchasers of the notes an option, exercisable within a 30-day period, to purchase up to an
Apr 17, 2019 09:46 pm ET
Aphria Announces Pricing of US$300 Million of Convertible Senior Notes
LEAMINGTON, ON, April 17, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the pricing of US$300 million aggregate principal amount of 5.25% convertible senior notes due 2024 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Act"), and outside the United States to non-U.S. persons in compliance with Regulation S under the Act. Aphria also granted the initial purchasers of the notes an option, exercisable within a 30-day period, to purchase u...
Apr 16, 2019 06:38 pm ET
Aphria Announces Proposed Private Offering of US$300 Million of Convertible Senior Notes Due 2024
LEAMINGTON, ON, April 16, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA), a leading global cannabis company, today announced that it proposes to offer pursuant to a private placement US$300 million aggregate principal amount of convertible senior notes due 2024 (the "notes"), subject to market conditions and other factors. Aphria also intends to grant to the initial purchasers of the notes an option, exercisable within 30-day period, to purchase up to an additional US$45 million aggregate principal amount of notes. The notes are to be offered and sold to qual
Apr 16, 2019 06:38 pm ET
Aphria Announces Proposed Private Offering of US$300 Million of Convertible Senior Notes Due 2024
LEAMINGTON, ON, April 16, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA), a leading global cannabis company, today announced that it proposes to offer pursuant to a private placement US$300 million aggregate principal amount of convertible senior notes due 2024 (the "notes"), subject to market conditions and other factors. Aphria also intends to grant to the initial purchasers of the notes an option, exercisable within 30-day period, to purchase up to an additional US$45 million aggregate principal amount of notes. The notes are to be offered and sold ...
Apr 15, 2019 06:05 am ET
Aphria Announces Third Quarter Fiscal 2019 Financial Results
Provides update regarding Green Growth Brands bidAppoints Walter Robb and David Hopkinson as independent directors to Board of DirectorsNet revenue of $73.6 million up 240% from prior quarter and 617% from prior year periodCurrent annualized production capacity of 115,000 kilograms
Apr 15, 2019 06:05 am ET
Aphria Announces Third Quarter Fiscal 2019 Financial Results
Provides update regarding Green Growth Brands bidAppoints Walter Robb and David Hopkinson as independent directors to Board of DirectorsNet revenue of $73.6 million up 240% from prior quarter and 617% from prior year periodCurrent annualized production capacity of 115,000 kilograms...
Apr 15, 2019 06:00 am ET
Aphria Agrees to Accelerate Expiry of Green Growth Brands Bid and Terminate its Option With GA Opportunities Corp.
LEAMINGTON, ON, April 15, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that it has entered into a series of transactions that will accelerate the expiry date to April 25, 2019 for the previously announced take-over bid by Green Growth Brands Inc. ("GGB") and will terminate the arrangements with GA Opportunities Corp. ("GAOC") for consideration of $89.0 million.
Apr 15, 2019 06:00 am ET
Aphria Agrees to Accelerate Expiry of Green Growth Brands Bid and Terminate its Option With GA Opportunities Corp.
LEAMINGTON, ON, April 15, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that it has entered into a series of transactions that will accelerate the expiry date to April 25, 2019 for the previously announced take-over bid by Green Growth Brands Inc. ("GGB") and will terminate the arrangements with GA Opportunities Corp. ("GAOC") for consideration of $89.0 million....
Apr 11, 2019 08:30 am ET
Cannabis Retail Giants: 5 Companies Making Big Moves
The cannabis industry is evolving rapidly, and we've seen some big moves happening lately that are going to have a significant impact on the retail environment both locally and internationally. Below are five companies you should be familiar with...
Apr 10, 2019 10:54 am ET
The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness  
Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum. According to one...
Apr 09, 2019 08:30 am ET
The Most Prevalent Cannabis E-commerce Platforms in Canada
Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures. However, given that only two of Canada's ten provinces—Manitoba and Saskatchewan—currently allow...
Apr 08, 2019 09:00 am ET
CBD Makes its Own Odds: Large-Scale Distributor Plans + Positive CBD Financials Bolster Market Despite Regulatory Issues
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a market snapshot discussing how the recent influx of positive 2018 financials have helped embolden the CBD market and showcase its progress in spite of...
Apr 05, 2019 08:08 am ET
Aphria Awarded Provisional Approval in Germany for Cannabis Cultivation License
LEAMINGTON, ON, April 5, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") has been selected by the German Federal Institute for Drugs and Medical Devices ("BfArM") to receive a license for the domestic cultivation of medical cannabis. The provisional decision announced by BfArM is subject to a mandatory 10-day standstill period for public contracts (the "Standstill"), which permits unsuccessful bidders to challenge the decision before the final contract is signed. BfArM's deci
Apr 05, 2019 08:08 am ET
Aphria Awarded Provisional Approval in Germany for Cannabis Cultivation License
LEAMINGTON, ON, April 5, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") has been selected by the German Federal Institute for Drugs and Medical Devices ("BfArM") to receive a license for the domestic cultivation of medical cannabis. The provisional decision announced by BfArM is subject to a mandatory 10-day standstill period for public contracts (the "Standstill"), which permits unsuccessful bidders to challenge the decision before the final contract is signed. BfArM...
Apr 01, 2019 03:00 am ET
Aphria Introduces CannRelief, a CBD-based Nutraceutical and Cosmetics Product Line, for the German Market
CannRelief CBD oils are the first product among many to be launched as part of the skincare and cosmetic product line
Apr 01, 2019 03:00 am ET
Aphria Introduces CannRelief, a CBD-based Nutraceutical and Cosmetics Product Line, for the German Market
CannRelief CBD oils are the first product among many to be launched as part of the skincare and cosmetic product line...
Mar 28, 2019 06:30 am ET
Aphria to Announce Third Quarter Fiscal 2019 Financial Results on April 15, 2019
LEAMINGTON, ON, March 28, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) will release financial results for the fiscal third quarter and nine months ended February 28, 2019 on April 15, 2019 before market open.
Mar 28, 2019 06:30 am ET
Aphria to Announce Third Quarter Fiscal 2019 Financial Results on April 15, 2019
LEAMINGTON, ON, March 28, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) will release financial results for the fiscal third quarter and nine months ended February 28, 2019 on April 15, 2019 before market open....
Mar 04, 2019 05:30 am ET
Aphria Receives Health Canada License Amendment, Approving Fully Expanded Production at Aphria One
Annual cannabis production capacity at Aphria One increases to 110,000 kg and 115,000 kgs for all licensed facilities
Mar 04, 2019 05:30 am ET
Aphria Receives Health Canada License Amendment, Approving Fully Expanded Production at Aphria One
Annual cannabis production capacity at Aphria One increases to 110,000 kg and 115,000 kgs for all licensed facilities...
Feb 26, 2019 05:30 am ET
Aphria signs worldwide license agreement with Manna Molecular Science to develop state-of-the-art cannabis transdermal patches
LEAMINGTON, ON and WORCESTER, MA, Feb. 26, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced a worldwide license agreement with Manna Molecular Science, LLC ("Manna"), producers of state-of-the-art cannabis transdermal patches. Leveraging Manna's established formulations, equipment and processes, Aphria will produce and sell patches containing cannabis oils for its established suite of medical and adult-use brands.
Feb 26, 2019 05:30 am ET
Aphria signs worldwide license agreement with Manna Molecular Science to develop state-of-the-art cannabis transdermal patches
LEAMINGTON, ON and WORCESTER, MA, Feb. 26, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced a worldwide license agreement with Manna Molecular Science, LLC ("Manna"), producers of state-of-the-art cannabis transdermal patches. Leveraging Manna's established formulations, equipment and processes, Aphria will produce and sell patches containing cannabis oils for its established suite of medical and adult-use brands....
Feb 25, 2019 09:00 am ET
4 Companies Shaping the Cannabis Retail Market
The cannabis retail market remains one of marijuana's biggest unknowns. Companies have been working on different approaches when it comes to developing stores or products that will appeal to consumers. It will take time before we see which...
Feb 19, 2019 05:28 pm ET
Aphria announces early termination and liquidation of interests in Liberty Health Sciences, Inc.
Cash proceeds of $47 million received, with additional $10 million upon satisfaction of certain conditions
Feb 19, 2019 05:28 pm ET
Aphria announces early termination and liquidation of interests in Liberty Health Sciences, Inc.
Cash proceeds of $47 million received, with additional $10 million upon satisfaction of certain conditions...
Feb 15, 2019 06:42 am ET
Aphria Announces Conclusion of Special Committee Review
Special Committee concludes that acquisition of LATAM assets was within an acceptable range as compared to similar acquisitions by competitors
Feb 15, 2019 06:42 am ET
Aphria Announces Conclusion of Special Committee Review
Special Committee concludes that acquisition of LATAM assets was within an acceptable range as compared to similar acquisitions by competitors ...
Feb 14, 2019 08:00 am ET
EU Parliament and WHO Could Blow the Lid off The Cannabis Sector: Who’s Ready for the Next Phase?
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how recent developments in the EU Parliament as well as WHO (World Health Organization) could have massive impacts on the cannabis...
Feb 08, 2019 05:30 am ET
Aphria Appoints Brett D. Marchand as Senior Vice President of Supply Chain
LEAMINGTON, ON, Feb. 8, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the appointment of Brett D. Marchand as Senior Vice President of Supply Chain effective February 11, 2019. Previously, Mr. Marchand was Vice President of Supply Chain and Logistics Canada at The Northwest Company ("NWC") where he was responsible for overseeing a supply network that supported 140 remote access retail grocery and general merchandise stores across Canada's North.
Feb 08, 2019 05:30 am ET
Aphria Appoints Brett D. Marchand as Senior Vice President of Supply Chain
LEAMINGTON, ON, Feb. 8, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the appointment of Brett D. Marchand as Senior Vice President of Supply Chain effective February 11, 2019. Previously, Mr. Marchand was Vice President of Supply Chain and Logistics Canada at The Northwest Company ("NWC") where he was responsible for overseeing a supply network that supported 140 remote access retail grocery and general merchandise stores across Canada's North....
Feb 07, 2019 08:00 am ET
Q1 Results Fuel Expansion in the Cannabis Sector; Where’s Weed Going Now?
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the rapid expansion plans coming to the market after strong Q1 Financials. Q1 2019 is turning out to be quite the boon for many...
Feb 06, 2019 08:00 am ET
Top Tier Management Crushing The Cannabis Sector as Sector Matures
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks , looks at the growing demand to fill top tier management positions as the sector enters a new era of maturity.  In a recent Forbes article, Jay Czarkowski,...
Feb 06, 2019 05:00 am ET
Aphria's Board of Directors Rejects Green Growth Brand's Hostile Takeover Bid as Significantly Undervalued and Inadequate
LEAMINGTON, ON, Feb. 6, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Board of Directors (the "Board") has rejected the hostile bid by Green Growth Brands Inc. (CSE:GGB) ("GGB") to acquire all of the outstanding common shares of the Company ("Common Shares") including any Common Shares that may become issued and outstanding after January 22, 2019, but prior to the expiry of the hostile bid upon the exercise, conversion or exchange of options, warrants, debentures or other securities of the Company exercisable or convertible into Comm
Feb 06, 2019 05:00 am ET
Aphria's Board of Directors Rejects Green Growth Brand's Hostile Takeover Bid as Significantly Undervalued and Inadequate
LEAMINGTON, ON, Feb. 6, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Board of Directors (the "Board") has rejected the hostile bid by Green Growth Brands Inc. (CSE:GGB) ("GGB") to acquire all of the outstanding common shares of the Company ("Common Shares") including any Common Shares that may become issued and outstanding after January 22, 2019, but prior to the expiry of the hostile bid upon the exercise, conversion or exchange of options, warrants, debentures or other securities of the Company exercisable or convertible in...
Feb 04, 2019 12:25 pm ET
Cannabis Retailers: The Dawn of a New Industry
Mugglehead believes that Canadian cannabis retailers will be the next big focus for the industry. The current marijuana retail industry is practically non-existent today. Not only that, the shopping experience from retailer to retailer, even...
Feb 01, 2019 02:00 am ET
Aphria Introduces First Cannabis Strains to be Produced in Europe with Export to Danish Partner Schroll Medical
LEAMINGTON, ON, Feb. 1, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical ("Schroll"), as part of the Company's previously announced Strategic Partnership (the "Partnership") with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agen
Feb 01, 2019 02:00 am ET
Aphria Introduces First Cannabis Strains to be Produced in Europe with Export to Danish Partner Schroll Medical
LEAMINGTON, ON, Feb. 1, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical ("Schroll"), as part of the Company's previously announced Strategic Partnership (the "Partnership") with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspecti...
Jan 30, 2019 08:00 am ET
Cannabis Growth Continues to Drive Technology Innovation for EnviroTechnologies International, Canopy Rivers, Aphria and WeedMD
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on how the cannabis industry continues to force technology innovation as it faces new challenges with the sector’s continuing rapid...
Jan 23, 2019 07:04 am ET
IIROC Trade Resumption - APHA
TORONTO, Jan. 23, 2019 /CNW/ - Trading resumes in:
Jan 22, 2019 10:33 pm ET
Aphria Urges Shareholders to Take No Action With Respect to Unsolicited Takeover Bid by Green Growth Brands
LEAMINGTON, ON, Jan. 22, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today confirmed that Green Growth Brands Inc. (CSE:GGB) ("GGB") has commenced an unsolicited take-over bid (the "Offer") to acquire all outstanding common shares of the Company, other than the common shares of the Company owned by GGB or its affiliates, in exchange for 1.5714 common shares of GGB.
Jan 22, 2019 10:33 pm ET
Aphria Urges Shareholders to Take No Action With Respect to Unsolicited Takeover Bid by Green Growth Brands
LEAMINGTON, ON, Jan. 22, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today confirmed that Green Growth Brands Inc. (CSE:GGB) ("GGB") has commenced an unsolicited take-over bid (the "Offer") to acquire all outstanding common shares of the Company, other than the common shares of the Company owned by GGB or its affiliates, in exchange for 1.5714 common shares of GGB....
Jan 22, 2019 03:08 pm ET
IIROC Trading Halt - APHA
TORONTO, Jan. 22, 2019 /CNW/ - The following issues have been halted by IIROC:
Jan 18, 2019 05:45 am ET
Aphria and UNOapp to Partner on Technology and Analytics Solutions for the Adult-Use Cannabis Industry
LEAMINGTON, ON, Jan. 18, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has recently entered into an exclusive agreement (the "Agreement") with Toronto-based UNOapp Inc. ("UNOapp") to collaborate on the development of technology and analytics solutions for Canada's adult-use cannabis industry.
Jan 18, 2019 05:45 am ET
Aphria and UNOapp to Partner on Technology and Analytics Solutions for the Adult-Use Cannabis Industry
LEAMINGTON, ON, Jan. 18, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has recently entered into an exclusive agreement (the "Agreement") with Toronto-based UNOapp Inc. ("UNOapp") to collaborate on the development of technology and analytics solutions for Canada's adult-use cannabis industry. ...
Jan 11, 2019 06:06 am ET
Aphria Records 63% Net Revenue Growth in Fiscal 2019 Second Quarter; Announces Executive Team Transition
Net revenue of $21.7 million up 63% from prior quarter on initial sales to Canadian adult-use market; adjusted gross profit of $10.2 million To accelerate the production ramp-up post-Health Canada approvals, yields were lowered to build stockpiles for expanded facilities and to implement highly automated cultivation and harvesting Licence applications submitted for facilities expansions; annualized harvest expected to increase to 255,000 kilograms by the end of calendar 2019 Successfully advanced international growth strategy with significant strategic alliances and investments in Europe and
Jan 11, 2019 06:06 am ET
Aphria Records 63% Net Revenue Growth in Fiscal 2019 Second Quarter; Announces Executive Team Transition
Net revenue of $21.7 million up 63% from prior quarter on initial sales to Canadian adult-use market; adjusted gross profit of $10.2 million To accelerate the production ramp-up post-Health Canada approvals, yields were lowered to build stockpiles for expanded facilities and to implement highly automated cultivation and harvesting Licence applications submitted for facilities expansions; annualized harvest expected to increase to 255,000 kilograms by the end of calendar 2019 Successfully advanced international growth strategy with significant strategic alliances and investments in Europe and...
Jan 09, 2019 08:00 am ET
Cannabis Companies Expanding Global Footprint; The Greater Cannabis Company Inc. (OTC:GCAN), Aphria, Canopy Growth and AgraFlora Organics
Investorideas.com, a leading investor news resource covering cannabis stocks releases a snapshot looking at the global expansion of the cannabis industry and the companies looking at new international markets as regulations change. As new...
Jan 09, 2019 02:00 am ET
Aphria Completes Acquisition of CC Pharma, Leading German Pharmaceutical and Medical Cannabis Distributor
LEAMINGTON, ON, Jan. 9, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that it had completed its previously announced acquisition of CC Pharma GmbH ("CC Pharma"), a leading distributor of pharmaceutical products, including medical cannabis, to more than 13,000 pharmacies in Germany, as well as throughout Europe.  The Company continues to strengthen its end-to-end cannabis operations and infrastructure in Germany.
Jan 09, 2019 02:00 am ET
Aphria Completes Acquisition of CC Pharma, Leading German Pharmaceutical and Medical Cannabis Distributor
LEAMINGTON, ON, Jan. 9, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that it had completed its previously announced acquisition of CC Pharma GmbH ("CC Pharma"), a leading distributor of pharmaceutical products, including medical cannabis, to more than 13,000 pharmacies in Germany, as well as throughout Europe.  The Company continues to strengthen its end-to-end cannabis operations and infrastructure in Germany....
Jan 08, 2019 06:21 pm ET
Aphria completes first shipment of medical cannabis to Shoppers Drug Mart
LEAMINGTON, ON, Jan. 8, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) announced today that it has completed its first shipment of medical cannabis to Shoppers Drug Mart ("SDM").
Jan 08, 2019 06:21 pm ET
Aphria completes first shipment of medical cannabis to Shoppers Drug Mart
LEAMINGTON, ON, Jan. 8, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) announced today that it has completed its first shipment of medical cannabis to Shoppers Drug Mart ("SDM")....
Jan 02, 2019 06:00 am ET
Aphria's Colombian Subsidiary, Colcanna, Inks Exclusive Agreement with Colombian Medical Federation
LEAMINGTON, ON, Jan. 2, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Colombian subsidiary, Colcanna SAS ("Colcanna") has signed an exclusive agreement (the "Agreement") with the Federación Médica Colombiana ("FMC"), a national guild that oversees the ethical exercise of the medical profession in Colombia, to jointly develop an academic curriculum on the medicinal use of cannabis.
Jan 02, 2019 06:00 am ET
Aphria's Colombian Subsidiary, Colcanna, Inks Exclusive Agreement with Colombian Medical Federation
LEAMINGTON, ON, Jan. 2, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Colombian subsidiary, Colcanna SAS ("Colcanna") has signed an exclusive agreement (the "Agreement") with the Federación Médica Colombiana ("FMC"), a national guild that oversees the ethical exercise of the medical profession in Colombia, to jointly develop an academic curriculum on the medicinal use of cannabis....
Dec 31, 2018 03:04 pm ET
Green Growth Brands Reaffirms Commitment to Takeover Aphria Inc.
Green Growth Brands Inc. (“Green Growth”) (CSE: GGB) reaffirms its commitment to launch an offer (the “Offer”) to purchase all of the issued and outstanding common shares of Aphria Inc. (“Aphria”) (TSX: APHA and NYSE: APHA) which it does not...
Dec 28, 2018 06:57 am ET
IIROC Trade Resumption - APHA
TORONTO, Dec. 28, 2018 /CNW/ - Trading resumes in:
Dec 28, 2018 05:30 am ET
Aphria Responds to Unsolicited Proposal by Green Growth Brands
LEAMINGTON, ON, Dec. 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today responds to the unsolicited proposal by Xanthic Biopharma Inc. d.b.a. Green Growth Brands Ltd. (CSE:GGB) ("GGB") to acquire all of the Company's outstanding common shares in an all-stock transaction. 
Dec 27, 2018 04:47 pm ET
Green Growth Brands Announces Intention to Launch Takeover Bid for Aphria Inc.
Xanthic Biopharma Inc. doing business as Green Growth Brands Ltd. (“Green Growth”) (CSE: GGB) announced today that it currently intends to make an offer (the “Offer”) to purchase all of the issued and outstanding common shares (the “Aphria Shares”)...
Dec 27, 2018 04:00 pm ET
Aphria Appoints Irwin D. Simon as Independent Chair of Board of Directors
Seasoned Executive and Entrepreneur Brings Substantial Public Company Operating and Brand Management Experience
Dec 27, 2018 04:00 pm ET
Aphria Appoints Irwin D. Simon as Independent Chair of Board of Directors
Seasoned Executive and Entrepreneur Brings Substantial Public Company Operating and Brand Management Experience...
Dec 27, 2018 03:14 pm ET
IIROC Trading Halt - APHA
TORONTO, Dec. 27, 2018 /CNW/ - The following issues have been halted by IIROC:
Dec 21, 2018 04:30 pm ET
Aphria to Announce Second Quarter Results on January 11, 2019
LEAMINGTON, ON, Dec. 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) will release its second quarter results for 2019 on January 11, 2019.
Dec 21, 2018 04:30 pm ET
Aphria to Announce Second Quarter Results on January 11, 2019
LEAMINGTON, ON, Dec. 21, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) will release its second quarter results for 2019 on January 11, 2019....
Dec 20, 2018 04:30 pm ET
Aphria Completes Second Medical Cannabis Shipment to Australia-Based Partner Althea
LEAMINGTON, ON, Dec. 20, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) announced that the Company has completed its second shipment of approximately 80 L (equivalent to approximately 20 kg of dried bud) of medical cannabis to its Australian-based partner Althea Company Pty Ltd. ("Althea").
Dec 20, 2018 05:30 am ET
Aphria signs LOI with CANNAVA to expand strategic Argentinian operations into Province of Jujuy
LEAMINGTON, ON and JUJUY, Argentina, Dec. 20, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its subsidiary ABP S.A. ("ABP") has signed a Letter of Intent ("LOI") with the Argentinian state-owned Cannabis Avatãra Sociedad del Estado ("CANNAVA") to enter into a cooperation agreement regarding the cultivation of cannabis that will expand the Company's strategic Argentinian operations into the Province of Jujuy.
Dec 18, 2018 07:44 am ET
Rapid Dose Therapeutics and Aphria to Deliver Innovative QuickStrip(TM) Technology to the German Cannabis Market
Burlington, Ontario and Leamington, Ontario--(Newsfile Corp. - December 18, 2018) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT" or the "Company")  and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) announced today that they have expanded the scope of their previously announced agreement (the "Agreement"), executed on November 1, 2018 (see the Company's press release dated November 5, 2018), expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture, distribute and sell RDT's QuickStrip™ innovative, proprietary delivery technology for the cannabis market to Germany.
Dec 18, 2018 05:30 am ET
Aphria and Rapid Dose Therapeutics to Introduce Innovative QuickStrip™ Oral Thin Strips to German Cannabis Market
LEAMINGTON, ON and BURLINGTON, ON, Dec. 18, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) and Rapid Dose Therapeutics Inc. ("RDT") (CSE: DOSE) announced today that they have expanded the scope of their previously announced agreement (the "Agreement") expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture, distribute and sell RDT's QuickStrip™ innovative, proprietary delivery technology for the cannabis market to Germany.
Dec 12, 2018 06:00 am ET
Aphria Signs Letter of Intent for Exclusive Supply Agreement with Insumos Medicos, S.A. to Supply Medical Cannabis in Paraguay
LEAMINGTON, ON, Dec. 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that it has signed a Letter of Intent (the "LOI") with Insumos Medicos S.A. ("Insumos"), a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay.
Dec 12, 2018 06:00 am ET
Aphria Signs Letter of Intent for Exclusive Supply Agreement with Insumos Medicos, S.A. to Supply Medical Cannabis in Paraguay
LEAMINGTON, ON, Dec. 12, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that it has signed a Letter of Intent (the "LOI") with Insumos Medicos S.A. ("Insumos"), a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay....
Dec 07, 2018 05:00 pm ET
APHRIA INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of
Wolf Haldenstein Adler Freeman & Herz LLP  announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased or otherwise acquired...
Dec 06, 2018 05:30 am ET
Aphria Announces Special Committee to Review Governance Processes Related to LATAM Acquisition
Board reiterates confidence in LATAM operations and strategy Undertakes comprehensive review to protect shareholders in face of inaccurate and misleading accusations by short-sellers LEAMINGTON, ON, Dec. 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced its Board of Directors has appointed a special committee (the "Special Committee") of independent directors to review the Company's previously completed acquisition of LATAM Holdings Inc. (the "Acquisition"), which closed on September 27, 2018, and confirm the Company's belief that it conform
Dec 06, 2018 05:30 am ET
Aphria Announces Special Committee to Review Governance Processes Related to LATAM Acquisition
Board reiterates confidence in LATAM operations and strategy Undertakes comprehensive review to protect shareholders in face of inaccurate and misleading accusations by short-sellers LEAMINGTON, ON, Dec. 6, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced its Board of Directors has appointed a special committee (the "Special Committee") of independent directors to review the Company's previously completed acquisition of LATAM Holdings Inc. (the "Acquisition"), which closed on September 27, 2018, and confirm the Company's belief that it ...
Dec 04, 2018 07:21 am ET
Aphria Unequivocally Stands Behind its LATAM Operations
Assets Well Positioned to Create Substantial Value for Shareholders Executive Management Demonstrates Belief in Company Through $3.1M Acquisition of Shares on December 3, 2018 LEAMINGTON, ON, Dec. 4, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today provides the following update on its Latin American operations, including its previously completed LATAM acquisition of LATAM Holdings Inc. consisting of licenses and other assets and related businesses in Colombia, Argentina and Jamaica and a right of first offer and refusal in respect of Brazil (collectively
Dec 04, 2018 07:21 am ET
Aphria Unequivocally Stands Behind its LATAM Operations
Assets Well Positioned to Create Substantial Value for Shareholders Executive Management Demonstrates Belief in Company Through $3.1M Acquisition of Shares on December 3, 2018 LEAMINGTON, ON, Dec. 4, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today provides the following update on its Latin American operations, including its previously completed LATAM acquisition of LATAM Holdings Inc. consisting of licenses and other assets and related businesses in Colombia, Argentina and Jamaica and a right of first offer and refusal in respect of Brazil (colle...
Dec 03, 2018 02:00 pm ET
Aphria statement regarding short-seller report
LEAMINGTON, ON, Dec. 3, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) is aware of a short-seller report released earlier today which Aphria believes is a malicious and self-serving attempt to profit by manipulating Aphria's stock price at the expense of Aphria's shareholders.
Dec 03, 2018 02:00 pm ET
Aphria statement regarding short-seller report
LEAMINGTON, ON, Dec. 3, 2018 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) is aware of a short-seller report released earlier today which Aphria believes is a malicious and self-serving attempt to profit by manipulating Aphria's stock price at the expense of Aphria's shareholders....
Nov 30, 2018 05:02 pm ET
Tetra Bio-Pharma Closes Financing With Aphria Inc.
Tetra Bio-Pharma Inc (“Tetra” or “TBP”), (TSX VENTURE: TBP) (OTCQB: TBPMF), has closed a private placement of units (the “Private Placement”) with its strategic partner Aphria Inc. (“Aphria”) (TSX: APHA) (NYSE: APHA). Under the Private Placement,...
Nov 29, 2018 10:00 am ET
Blending the Talent of the Beverage Industry to Create the Cannabis Drinks of the Future: Sproutly (SPR: CSE) (OTCQB: SRUTF), Corby Spirit and Wine Limited, Pernod Ricard SA, Aphria and HEXO Corporati
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on the shift and demand for seasoned beverage industry experts to enter  the rapidly growing cannabis...
Nov 08, 2018 04:00 am ET
Aphria to acquire CC Pharma, strengthening foothold in German medical cannabis market
Acquisition adds new vertical and strategic operations in key region of global growth strategy
Nov 08, 2018 04:00 am ET
Aphria to acquire CC Pharma, strengthening foothold in German medical cannabis market
Acquisition adds new vertical and strategic operations in key region of global growth strategy ...
Nov 07, 2018 06:00 am ET
Aphria and DCM Subsidiary Perennial Launch Joint Venture to Create Original, Consumer-Centric Brands Offering Cannabis-Infused Products
Joint venture partners Aphria's cannabis expertise with Perennial's international brand strategy experience
Nov 07, 2018 06:00 am ET
Aphria and DCM Subsidiary Perennial Launch Joint Venture to Create Original, Consumer-Centric Brands Offering Cannabis-Infused Products
Joint venture partners Aphria's cannabis expertise with Perennial's international brand strategy experience...
Nov 05, 2018 09:31 am ET
Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria
Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world.
Nov 05, 2018 06:30 am ET
Aphria Shareholders Elect Four New Directors
LEAMINGTON, ON, Nov. 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the results of the shareholder resolutions considered at the Company's Annual and Special Meeting of Shareholders (the "Meeting") held on November 2, 2018.
Nov 01, 2018 11:43 pm ET
Aphria's Australian-Based Partner Althea Granted Manufacture Licence
LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.